Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $1.7 million.

  • Lemaitre Vascular's Share-based Compensation rose 807.45% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 1982.99%. This contributed to the annual value of $6.6 million for FY2024, which is 2348.19% up from last year.
  • Per Lemaitre Vascular's latest filing, its Share-based Compensation stood at $1.7 million for Q3 2025, which was up 807.45% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Share-based Compensation registered a high of $2.0 million during Q1 2025, and its lowest value of $684000.0 during Q4 2022.
  • Moreover, its 5-year median value for Share-based Compensation was $1.3 million (2023), whereas its average is $1.3 million.
  • In the last 5 years, Lemaitre Vascular's Share-based Compensation plummeted by 2279.91% in 2022 and then skyrocketed by 10526.32% in 2023.
  • Over the past 5 years, Lemaitre Vascular's Share-based Compensation (Quarter) stood at $886000.0 in 2021, then dropped by 22.8% to $684000.0 in 2022, then soared by 105.26% to $1.4 million in 2023, then increased by 23.86% to $1.7 million in 2024, then rose by 0.06% to $1.7 million in 2025.
  • Its Share-based Compensation was $1.7 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.0 million in Q1 2025.